WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 29, 2006--NanoViricides, Inc. (Pink Sheets: NNVC) revealed new details of its work in the fight against Bird Flu at a gathering of cutting-edge researchers at the Cambridge Healthcare Institute's conference "Novel Vaccines: Bridging Research, Development and Production" in Boston last week.
